ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion strategy for ophthalmic ...
Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment D.O.R.C., a leading player in the retinal surgical ...
ZEISS Research Data Platform launch - a cloud-based, AI-driven technology solution designed to accelerate discoveries, integrating research and clinical data, and simplifying research workflows. ZEISS ...
“With this surgical microscope ZEISS is expanding its product range for primary health care, particularly for customers in the fast-growing Asian and Latin American markets,” says Dr. Ludwin Monz, ...
Today, ZEISS marks 100 years of operation in the U.S., helping Americans improve lives and reach profound achievements by applying the company's innovative technologies to research, healthcare, ...
Carl Zeiss Meditec AG (CZMWF) reported solid revenue growth of 7.8% year over year, reaching 2,228 million. Order entry increased by 18.2% year over year, indicating strong demand across all regions.
Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment JENA, Germany, Dec. 15, 2023 /PRNewswire/ -- Carl ...
The MarketWatch News Department was not involved in the creation of this content. Today, ZEISS marks 100 years of operation in the U.S., helping Americans improve lives and reach profound achievements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback